NCT00739908 - A Study of CX157 (TriRima) for the Treatment of Depression | Biotech Hunter

Enrollment

285

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Major Depressive Disorder

Interventions

DRUG

CX157 (TriRima)

Six capsules administered three times a day for six weeks.

DRUG

Placebo

Six capsules administered three times a day for six weeks.

Trial Locations (14)

Irving S. Kolin, M.D., Winter Park

Birmingham Research Group, Birmingham

FutureSearch Trials, Austin

Southwestern Research, Inc., Beverly Hills

The George Washington University, Washington D.C.

Midwest Center for Neurobehavioral Medicine, Oakbrook Terrace

Capital Clinical Research Associates, Rockville

McLean Hospital, Belmont

CRI Worldwide, LLC, Clementon

Fieve Clinical Services, New York

Richard H. Weisler, M.D., P.A., Raleigh

University of Pennsylvania School of Medicine, Philadelphia

Summit Research Network (Seattle), LLC, Seattle

Northbrooke Research Center, Brown Deer